Caroline de Gouveia Buff Passone,Gaëlle Vermillac,Willem Staels,Alix Besancon,Dulanjalee Kariyawasam,Cécile Godot,Cécile Lambe,Cécile Talbotec,Muriel Girard,Christophe Chardot,Laureline Berteloot,Taymme Hachem,Alexandre Lapillonne,Amélie Poidvin,Caroline Storey,Mathieu Neve,Cosmina Stan,Emmanuelle Dugelay,Anne-Laure Fauret-Amsellem,Yline Capri,Hélène Cavé,Marina Ybarra,Vikash Chandra,Raphaël Scharfmann,Elise Bismuth,Michel Polak,Jean Claude Carel,Bénédicte Pigneur,Jacques Beltrand

Abstract:Aims/hypothesis: Caused by biallelic mutations of the gene encoding the transcription factor RFX6, the rare Mitchell-Riley syndrome (MRS) comprises neonatal diabetes, pancreatic hypoplasia, gallbladder agenesis or hypoplasia, duodenal atresia, and severe chronic diarrhea. So far, sixteen cases have been reported, all with a poor prognosis. This study discusses the multidisciplinary intensive clinical management of 4 new cases of MRS that survived over the first 2 years of life. Moreover, it demonstrates how the mutations impair the RFX6 function. Methods: Clinical records were analyzed and described in detail. The functional impact of two RFX6R181W and RFX6V506G variants was assessed by measuring their ability to transactivate insulin transcription and genes that encode the L-type calcium channels required for normal pancreatic beta-cell function. Results: All four patients were small for gestational age (SGA) and prenatally diagnosed with duodenal atresia. They presented with neonatal diabetes early in life and were treated with intravenous insulin therapy before switching to subcutaneous insulin pump therapy. All patients faced recurrent hypoglycemic episodes, exacerbated when parenteral nutrition (PN) was disconnected. A sensor-augmented insulin pump therapy with a predictive low-glucose suspension system was installed with good results. One patient had a homozygous c.1517T>G (p.Val506Gly) mutation, two patients had a homozygous p.Arg181Trp mutation, and one patient presented with new compound heterozygosity. The RFX6V506G and RFX6R181W mutations failed to transactivate the expression of insulin and genes that encode L-type calcium channel subunits required for normal pancreatic beta-cell function. Conclusions/interpretation: Multidisciplinary and intensive disease management improved the clinical outcomes in four patients with MRS, including adjustment of parenteral/oral nutrition progression and advanced diabetes technologies. A better understanding of RFX6 function, in both intestine and pancreas cells, may break ground in new therapies, particularly regarding the use of drugs that modulate the enteroendocrine system.

Expanding the clinical phenotype and variant spectrum associated with RFX7

Phenotype expansion and neurological manifestations of neurobehavioural disease caused by a variant in RFX7

Disruption of RFX family transcription factors causes autism, attention-deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior

Case Report: Novel Splicing Mutations in RFX5 Causing MHC Class II Deficiency

Neonatal diabetes, gallbladder agenesis, duodenal atresia, and intestinal malrotation caused by a novel homozygous mutation in RFX6

Variants in ZFX are associated with an X-linked neurodevelopmental disorder with recurrent facial gestalt

Expanding the clinical and genetic spectrum of FDXR deficiency by functional validation of variants of uncertain significance

Case Report: FOXP1 Syndrome Caused by a De Novo Splicing Variant (c.1652+5 G>A) of the FOXP1 Gene.

Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis

How many phenotypes for the FBXO11 related disease? Report on a new patient with a tricho-rhino-phalangeal like phenotype

Broadening the phenotypic and molecular spectrum of FINCA syndrome: Biallelic NHLRC2 variants in 15 novel individuals

Expanding the phenotypic spectrum of TRAF7 -related CAFDADD: report of eleven new cases and literature review.

Recurrent FOXP4 nonsense variant in two unrelated patients: Association with neurodevelopmental disease and congenital diaphragmatic hernia

Identification of a Novel FOXP1 Variant in a Patient with Hypotonia, Intellectual Disability, and Severe Speech Impairment

Deep phenotyping of 11 individuals with pathogenic variants in RNU4-2 reveals a clinically recognizable syndrome

Mitchell-Riley Syndrome: Improving Clinical Outcomes and Searching for Functional Impact of RFX-6 Mutations

Expansion of the complex genotypic and phenotypic spectrum of FGFR2-associated neurocutaneous syndromes

Variable Anterior Segment Dysgenesis and Cardiac Anomalies Caused by a Novel Truncating Variant of FOXC1

De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features

FDXR-associated disease: a challenging differential diagnosis with inflammatory peripheral neuropathy

Case report: A novel FBXW7 gene variant causes global developmental delay